🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

10 years of the PGME program focused on developing the next generation of academic clinician educators! Such joy seeing this pic of our 2023 scholars. Unbelievable to be back in person! ⁦Boston Children's⁩ ⁦Icahn School of Medicine at Mount Sinai⁩ ⁦InstituteMedEdSinai⁩ #HMIPGME

What a dream team leading #HMIPGME 2023! Ten years & going strong! 👏🏼 🎉 Susan E. Farrell Alan Leichtner Reena Karani MD,MHPE Ginny Do

Fascinating history: Stanford Nephrology and Stanford Endocrinology both originated from the Division of Salt and Water Stanford Department of Medicine

OUT NOW! Feb 2024 Surgical Clinics 16 articles on #Liver #Transplantation @ surgical.theclinics.com Also @ScienceDirect + Elsevier | ClinicalKey Thanks to Editor Shimul A. Shah UC General Surgery + all authors for contributing! #transplant Elsevier Clinics Buy: bit.ly/47z5t6J

How things have changed already in 2024--this article seems outdated already--- Onconephrology: The intersections between the kidney and cancer acsjournals.onlinelibrary.wiley.com/doi/full/10.33… Mark Perazella Blaithin A. McMahon Mitch Rosner CA: A Cancer Journal for Clinicians

🔊 Exciting news! Our latest research on myeloma-associated thrombosis is now published in AmericanJournalofHematology: doi.org/10.1002/ajh.27… We found that the addition of carfilzomib as compared with bortezomib in Rd-based triplets for NDMM significantly increased the risk for VTE events

In NDMM, how does KRd compare to VRd regarding efficacy endpoints? Happy to share our new meta-analysis just published in AmericanJournalofHematology: doi.org/10.1002/ajh.27…. KRd-treated pts showed higher odds of achieving MRD negativity and CR/sCR compared to VRd-treated pts, while ORR,

Honored to meet Prabir Roy Chaudhury at the ISN-ANIO Clinical Trials Workshop—an inspiring leader in nephrology, especially for fellows. Grateful to be training during such an exciting time of progress in the field! #ISNWCN

Starting WCN on a high note! Had an incredible experience learning at the ISN-ANIO Clinical Trials Workshop—an inspiring lead-up to WCN!!Excited for the days ahead! #ISNWCN #WomenInNephrology

Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis | New England Journal of Medicine ⁦World Congress of Nephrology⁩ ⁦NEJM⁩ nejm.org/doi/full/10.10…

Poster viewing at the #ISNWCN with Joseph Vassalotti, MD from National Kidney Foundation and Neha Debnath, Nephrology fellow from Stanford Nephrology

So glad to finally meet Kenar Jhaveri and Anushree Shirali in person! #Onconephrology#ISNWCN

Grateful for the opportunity to present at WCN! Excited to contribute to bridging the gap between Oncology and Nephrology. Thank you Susan Ziolkowski Stanford Nephrology #OncoNephrology #ISNWCN

The time to act is now. If we do not act now, academic medicine as we know it will cease to exist. AAMC

An unforgettable moment at WCN 2025, witnessing women nephrologists from around the world in traditional Indian saris. A beautiful celebration of women’s unity, culture, and excellence in medicine #WomenInNephrology #WCN2025 #ISNWCN Prof Liz B 🇬🇧🇮🇱🇺🇦🇵🇸 Maria Jose Soler

Stanford Nephrology at #WCN2025! Missed taking a photo with Dr. Bhalla! Shuchi Anand Sankar Niranjan Laboratory of Vivek Bhalla, MD- Stanford Stanford Nephrology #ISNWCN

Feb 2025 Kidney News Clinical Trials Show Promise for Novel Treatments for IgA Nephropathy Bhadran Bose kidneynews.org/view/journals/… ASN Publications American Society of Nephrology

Excellent paper on AKI due to the cancer immunotherapies!!! From the Update on Onco-Nephrology series in Kidney360. journals.lww.com/kidney360/abst…

Also published in the Update on Onco-Nephrology series in Kidney360: Outstanding review on Assessing GFR in patients with cancer! journals.lww.com/kidney360/abst…